Cardiff Oncology Inc Net Asset Quality Index
Cardiff Oncology Inc net asset quality index. Cardiff Oncology Inc (CRDF) has a Net Asset Quality Index of 73.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $61.88 Million minus total liabilities of $16.50 Million yields net assets of $45.39 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Cardiff Oncology Inc's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cardiff Oncology Inc (2009–2025)
Net asset quality index of Cardiff Oncology Inc from 2009 to 2025. This chart shows how Cardiff Oncology Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the index stands at 73.3%, representing net assets of $45.39 Million against total assets of $61.88 Million USD. Check strategic asset allocation of Cardiff Oncology Inc to assess the company's strategic physical and investment asset allocation.
Cardiff Oncology Inc Net Asset Quality Index by Year (2009–2025)
Cardiff Oncology Inc net asset quality index by year from 2009 to 2025. The table below presents the year-by-year Net Asset Quality Index for Cardiff Oncology Inc from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Cardiff Oncology Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.3% | $45.39 Million | $61.88 Million | $16.50 Million | ▼ -12.0 pp |
| 2024 | 85.3% | $82.95 Million | $97.19 Million | $14.24 Million | ▼ -0.1 pp |
| 2023 | 85.4% | $69.74 Million | $81.64 Million | $11.90 Million | ▼ -6.1 pp |
| 2022 | 91.5% | $106.34 Million | $116.19 Million | $9.85 Million | ▼ -2.4 pp |
| 2021 | 93.9% | $140.42 Million | $149.54 Million | $9.13 Million | ▼ -1.2 pp |
| 2020 | 95.1% | $128.16 Million | $134.73 Million | $6.57 Million | ▲ +39.3 pp |
| 2019 | 55.9% | $7.31 Million | $13.09 Million | $5.78 Million | ▼ -15.3 pp |
| 2018 | 71.2% | $10.08 Million | $14.17 Million | $4.09 Million | ▲ +18.2 pp |
| 2017 | 53.0% | $6.51 Million | $12.29 Million | $5.78 Million | ▲ +8.0 pp |
| 2016 | 45.0% | $19.77 Million | $43.95 Million | $24.18 Million | ▼ -23.2 pp |
| 2015 | 68.2% | $48.70 Million | $71.45 Million | $22.75 Million | ▲ +39.3 pp |
| 2014 | 28.9% | $8.35 Million | $28.90 Million | $20.55 Million | ▼ -46.2 pp |
| 2013 | 75.1% | $20.39 Million | $27.16 Million | $6.76 Million | ▲ +56.5 pp |
| 2012 | 18.6% | $2.17 Million | $11.66 Million | $9.50 Million | ▲ +425.7 pp |
| 2011 | -407.1% | $-4.23 Million | $1.04 Million | $5.27 Million | ▲ +568.1 pp |
| 2010 | -975.2% | $-5.00 Million | $512.22K | $5.51 Million | ▼ -476.5 pp |
| 2009 | -498.7% | $-3.79 Million | $760.00K | $4.55 Million | — |